Pharmaceutical, biotechnology and medical products companies
July 30, 2018

Accenture Positioned as a Leader in an IDC MarketScape: Worldwide Life Sciences Research & Development Vendor Assessment on IT Outsourcing for Third Consecutive Time

NEW YORK; July 30, 2018 – For the third consecutive time, Accenture (NYSE: ACN) is positioned as a Leader in the IDC MarketScape vendor assessment covering IT outsourcing (ITO) across the life sciences research and development (R&D) industry. 
July 12, 2018

Accenture Named a Leader in Worldwide Life Sciences R&D BPO Services by IDC MarketScape for Third Consecutive Time

NEW YORK; July 12, 2018 – Accenture (NYSE: ACN) has been named a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering business process outsourcing (BPO) across the life sciences research and development (R&D) industry. This is the third consecutive time Accenture Life Sciences has achieved this prestigious ranking.
July 02, 2018

Accenture Seeks Emerging Innovators and Disruptors for Third Annual Accenture HealthTech Innovation Challenge

NEW YORK; July 2, 2018 – Accenture (NYSE: ACN) has kicked off the application period for the third annual Accenture HealthTech Innovation Challenge, which seeks to improve the way people access and manage healthcare.
June 20, 2018

Accenture Secures Frost & Sullivan Market Leadership Award for Real-world Evidence Enterprise Solutions

NEW YORK; June 20, 2018 – Accenture is the recipient of the 2018 Frost & Sullivan North American Market Leadership Award for real-world evidence (RWE) enterprise solutions.
January 10, 2018

Accenture Report Highlights What Patients Want in New Treatments; Two-Thirds Say: Better Outcomes, Not Brands

NEW YORK; Jan. 10, 2018 When launching new products, pharmaceutical companies should focus more on evidence-based solutions than just the product or brand, according to a new report from Accenture (NYSE: ACN) on product launches in the pharmaceutical industry
January 08, 2018

Nanowear Named Innovation Champion of the Accenture HealthTech Innovation Challenge

SAN FRANCISCO; Jan. 8, 2018 – Nanowear has been named the Innovation Champion of the Accenture (NYSE: ACN) HealthTech Innovation Challenge, which pairs leading-edge startups with prominent health and life sciences organizations to develop innovative technology solutions that improve the way people access and manage healthcare.
December 20, 2017

Accenture and Roche Collaborate to Enhance Digital Healthcare for Cancer Patients

NEW YORK; Dec. 20, 2017 – Accenture (NYSE: ACN) today announced a collaborative services agreement with Roche. Under the terms of this exclusive multi-year agreement, Accenture will provide digital data integration services to Roche’s NAVIFY Tumor Board solution.
December 11, 2017

Shionogi Signs Strategic Digital Transformation Agreement with Accenture

TOKYO; Dec. 11, 2017 – Accenture (NYSE: ACN) has signed consulting and strategic outsourcing agreements with Shionogi & Co., Ltd. ("Shionogi") and its subsidiary company, Shionogi Digital Science Co., Ltd. ("Shionogi Digital Science”) to help Shionogi with its digital transformation initiative.

 
November 07, 2017

Accenture Launches the Patient Experience Manager to Help Life Sciences Companies Improve Care and Value for Patient Services Programs

NEW YORK; Nov. 7, 2017 – Accenture (NYSE: ACN) has launched the Patient Experience Manager which gives life sciences companies a single view of patient interactions, enabling them to make real time improvements in the patient experience by evaluating and optimizing the effectiveness of each interaction. 
October 03, 2017

Accenture Collaborates with Veeva Systems to Advance Regulatory Information Management for the Life Sciences Industry

NEW YORK; Oct. 3, 2017 – Accenture (NYSE: ACN) today announced it is working with Veeva Systems (NYSE: VEEV), a leader in cloud-based software for the global life sciences industry, to bring Veeva Vault RIM – a transformative regulatory information management solution – to biopharma companies. The collaboration will help enable the industry to bring new medicines to patients faster.